2018 Q4 Form 10-Q Financial Statement

#000093454918000092 Filed on November 09, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2018 Q1
Revenue $49.20M $13.73M $62.09M
YoY Change 1322.87% -62.53% 601.3%
Cost Of Revenue $11.00M $1.180M $21.74M
YoY Change 109900.0% 3144.78%
Gross Profit $38.20M $12.54M $40.35M
YoY Change 1007.25% -65.77% 392.67%
Gross Profit Margin 77.64% 91.37% 64.98%
Selling, General & Admin $13.92M $9.040M $19.14M
YoY Change 4390.32% -63.68% 153.85%
% of Gross Profit 36.44% 72.09% 47.43%
Research & Development $80.00K $170.0K
YoY Change -66.67% -46.88%
% of Gross Profit 0.64% 0.42%
Depreciation & Amortization $11.50M $5.000M $5.344M
YoY Change 112.96% -12.28% -3.54%
% of Gross Profit 30.1% 39.87% 13.24%
Operating Expenses $24.30M $16.28M $24.63M
YoY Change 239.86% -47.07% 84.22%
Operating Profit $10.02M -$4.963M $8.970M
YoY Change -236.67% 1022.85% -177.49%
Interest Expense -$21.11M -$27.60M -$40.89M
YoY Change -79.41% -117.37%
% of Operating Profit -210.72% -455.85%
Other Income/Expense, Net -$20.99M -$27.60M -$40.89M
YoY Change -79.61% -117.35% -5975.0%
Pretax Income -$10.97M -$32.56M -$31.92M
YoY Change -90.05% -120.53% 193.38%
Income Tax $397.0K $306.0K $191.0K
% Of Pretax Income
Net Earnings -$11.37M -$33.20M -$32.04M
YoY Change -89.68% -120.95% 170.82%
Net Earnings / Revenue -23.11% -241.86% -51.6%
Basic Earnings Per Share -$0.67 -$0.63
Diluted Earnings Per Share -$229.0K -$0.67 -$632.8K
COMMON SHARES
Basic Shares Outstanding 49.64M shares 49.56M shares 50.64M shares
Diluted Shares Outstanding 49.64M shares 49.56M shares 50.63M shares

Balance Sheet

Concept 2018 Q4 2018 Q3 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $162.5M $140.4M $179.6M
YoY Change 18.92% -11.48% 23.69%
Cash & Equivalents $128.8M $109.6M $150.3M
Short-Term Investments $33.64M $30.84M $29.40M
Other Short-Term Assets $3.100M $3.100M $3.800M
YoY Change 6.9% -11.43% -77.11%
Inventory
Prepaid Expenses
Receivables $32.88M $10.57M $4.695M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $201.5M $157.1M $188.2M
YoY Change 44.22% -3.25% 10.92%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $8.195M $8.195M $8.195M
YoY Change 273.35% 258.8% 272.5%
Other Assets $236.0K $183.0K $1.193M
YoY Change 14.01% -52.09% 255.06%
Total Long-Term Assets $22.48M $63.17M $129.6M
YoY Change -86.71% -77.34% 25.64%
TOTAL ASSETS
Total Short-Term Assets $201.5M $157.1M $188.2M
Total Long-Term Assets $22.48M $63.17M $129.6M
Total Assets $223.9M $220.3M $317.8M
YoY Change -27.47% -50.07% 16.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.300M $9.100M $9.000M
YoY Change 3.75% 18.18% -23.08%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $31.04M $16.26M $48.98M
YoY Change 224.74% -40.9% 231.15%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.674M $1.874M $1.805M
YoY Change -52.87% -78.59% 375.0%
Total Long-Term Liabilities $1.674M $1.874M $1.805M
YoY Change -52.87% -78.59% 375.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.04M $16.26M $48.98M
Total Long-Term Liabilities $1.674M $1.874M $1.805M
Total Liabilities $32.71M $18.13M $50.78M
YoY Change 149.52% -50.0% 234.75%
SHAREHOLDERS EQUITY
Retained Earnings -$422.5M -$411.2M -$317.5M
YoY Change 32.04% 95.97% -10.31%
Common Stock $50.00K $50.00K $51.00K
YoY Change -1.96% -1.96% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $39.27M $39.27M $34.64M
YoY Change 13.37% 13.37% 0.0%
Treasury Stock Shares 2.920M shares 2.920M shares 1.729M shares
Shareholders Equity $189.4M $200.3M $265.5M
YoY Change
Total Liabilities & Shareholders Equity $223.9M $220.3M $317.8M
YoY Change -27.47% -50.07% 16.48%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2018 Q1
OPERATING ACTIVITIES
Net Income -$11.37M -$33.20M -$32.04M
YoY Change -89.68% -120.95% 170.82%
Depreciation, Depletion And Amortization $11.50M $5.000M $5.344M
YoY Change 112.96% -12.28% -3.54%
Cash From Operating Activities $13.40M -$2.100M $49.97M
YoY Change -161.19% -105.22% -5219.88%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $5.900M $11.60M -$36.30M
YoY Change -89.72% -583.33% -49.93%
Cash From Investing Activities $5.800M $11.60M -$36.31M
YoY Change -89.9% -583.33% -49.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $7.000K
YoY Change -72.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 $24.00K
YoY Change -100.0% -89.57%
NET CHANGE
Cash From Operating Activities 13.40M -2.100M $49.97M
Cash From Investing Activities 5.800M 11.60M -$36.31M
Cash From Financing Activities 0.000 0.000 $24.00K
Net Change In Cash 19.20M 9.500M $13.69M
YoY Change -46.07% -74.87% -118.69%
FREE CASH FLOW
Cash From Operating Activities $13.40M -$2.100M $49.97M
Capital Expenditures $0.00 $0.00
Free Cash Flow $13.40M $49.97M
YoY Change -161.19% -5219.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 actg A10 Warrant
A10Warrant
809400 shares
CY2017Q1 actg Beneficial Ownership Percentage Limit
BeneficialOwnershipPercentageLimit
0.60
CY2017Q1 actg Bridge Installment Shares
BridgeInstallmentShares
90000 shares
CY2017Q1 actg Bridge Warrant Share
BridgeWarrantShare
157000 shares
CY2017Q1 actg Bridgeloanstatedinterestrate
Bridgeloanstatedinterestrate
0.08
CY2017Q2 actg Cashpaidforprimarywarrantexercise
Cashpaidforprimarywarrantexercise
29300000 USD
CY2017Q3 actg Contingent Legal Fees
ContingentLegalFees
12173000 USD
actg Contingent Legal Fees
ContingentLegalFees
16036000 USD
CY2018Q3 actg Contingent Legal Fees
ContingentLegalFees
2949000 USD
actg Contingent Legal Fees
ContingentLegalFees
19745000 USD
CY2018Q3 actg Cumulative Unrealized Gain Loss Since Inception
CumulativeUnrealizedGainLossSinceInception
8140000 USD
CY2017Q4 actg Fair Valueof Profits Interest
FairValueofProfitsInterest
3041000 USD
CY2018Q3 actg Fair Valueof Profits Interest
FairValueofProfitsInterest
1422000 USD
CY2018Q3 actg Fair Valueof Profits Interest
FairValueofProfitsInterest
1422000 USD
CY2017Q1 actg Fair Valueof Profits Interest
FairValueofProfitsInterest
722000 USD
CY2016Q3 actg First Loan Warrant
FirstLoanWarrant
700000 USD
CY2017Q3 actg Gainon Conversionof Loanand Accrued Interest
GainonConversionofLoanandAccruedInterest
0 USD
actg Gainon Conversionof Loanand Accrued Interest
GainonConversionofLoanandAccruedInterest
2671000 USD
CY2018Q3 actg Gainon Conversionof Loanand Accrued Interest
GainonConversionofLoanandAccruedInterest
0 USD
actg Gainon Conversionof Loanand Accrued Interest
GainonConversionofLoanandAccruedInterest
0 USD
CY2017Q3 actg Gainonexerciseof Primary Warrant
GainonexerciseofPrimaryWarrant
0 USD
actg Gainonexerciseof Primary Warrant
GainonexerciseofPrimaryWarrant
-4616000 USD
CY2018Q3 actg Gainonexerciseof Primary Warrant
GainonexerciseofPrimaryWarrant
0 USD
actg Gainonexerciseof Primary Warrant
GainonexerciseofPrimaryWarrant
0 USD
CY2017Q3 actg Generalandadministrativeexpensesexcludingsharebasedcompensation
Generalandadministrativeexpensesexcludingsharebasedcompensation
3262000 USD
actg Generalandadministrativeexpensesexcludingsharebasedcompensation
Generalandadministrativeexpensesexcludingsharebasedcompensation
13297000 USD
CY2018Q3 actg Generalandadministrativeexpensesexcludingsharebasedcompensation
Generalandadministrativeexpensesexcludingsharebasedcompensation
6099000 USD
actg Generalandadministrativeexpensesexcludingsharebasedcompensation
Generalandadministrativeexpensesexcludingsharebasedcompensation
16394000 USD
actg Increase Decrease In Royalties And Contingent Legal Fees Payable
IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
5916000 USD
actg Increase Decrease In Royalties And Contingent Legal Fees Payable
IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
3864000 USD
actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
14593000 USD
CY2018Q3 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
1231000 USD
CY2017 actg Investmentin Miso Robotics
InvestmentinMisoRobotics
2250000 USD
CY2018Q3 actg Investmentin Miso Robotics
InvestmentinMisoRobotics
6000000 USD
CY2017Q4 actg Investmentincommonstock
Investmentincommonstock
90795000 USD
CY2018Q3 actg Investmentincommonstock
Investmentincommonstock
32538000 USD
CY2017Q4 actg Investmentsatfairvalue
Investmentsatfairvalue
104754000 USD
CY2018Q3 actg Investmentsatfairvalue
Investmentsatfairvalue
36648000 USD
CY2017Q4 actg Investmentwarrants
Investmentwarrants
13959000 USD
CY2018Q3 actg Investmentwarrants
Investmentwarrants
4110000 USD
CY2017Q3 actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
4073000 USD
actg Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
6106000 USD
CY2016Q3 actg Maximum Investmentin Veritone
MaximumInvestmentinVeritone
50000000 USD
CY2017Q3 actg Noncashstockcompensationgeneralandadministrative
Noncashstockcompensationgeneralandadministrative
1272000 USD
actg Noncashstockcompensationgeneralandadministrative
Noncashstockcompensationgeneralandadministrative
4833000 USD
CY2018Q3 actg Noncashstockcompensationgeneralandadministrative
Noncashstockcompensationgeneralandadministrative
566000 USD
actg Noncashstockcompensationgeneralandadministrative
Noncashstockcompensationgeneralandadministrative
1791000 USD
CY2017Q3 actg Noncashstockcompensationprofitsinterests
Noncashstockcompensationprofitsinterests
8181000 USD
actg Noncashstockcompensationprofitsinterests
Noncashstockcompensationprofitsinterests
8235000 USD
CY2018Q3 actg Noncashstockcompensationprofitsinterests
Noncashstockcompensationprofitsinterests
-576000 USD
actg Noncashstockcompensationprofitsinterests
Noncashstockcompensationprofitsinterests
-1619000 USD
CY2014 actg Numberofpatentportfoliosacquired
Numberofpatentportfoliosacquired
6 patent_portfolios
CY2015 actg Numberofpatentportfoliosacquired
Numberofpatentportfoliosacquired
3 patent_portfolios
CY2016 actg Numberofpatentportfoliosacquired
Numberofpatentportfoliosacquired
2 patent_portfolios
CY2017 actg Numberofpatentportfoliosacquired
Numberofpatentportfoliosacquired
1 patent_portfolios
CY2017Q4 actg Patents Accumulated Amortization
PatentsAccumulatedAmortization
382220000 USD
CY2018Q3 actg Patents Accumulated Amortization
PatentsAccumulatedAmortization
425990000 USD
CY2017Q4 actg Patents Net Of Accumulated Amortization
PatentsNetOfAccumulatedAmortization
61917000 USD
CY2018Q3 actg Patents Net Of Accumulated Amortization
PatentsNetOfAccumulatedAmortization
18147000 USD
CY2017Q4 actg Percentageofownership Miso Robotics
PercentageofownershipMisoRobotics
0.226
CY2018Q3 actg Percentageofownership Miso Robotics
PercentageofownershipMisoRobotics
0.30
CY2017Q2 actg Percentageofownership Veritone
PercentageofownershipVeritone
0.2
CY2017Q3 actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
241000 USD
actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
994000 USD
CY2018Q3 actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
84000 USD
actg Research Consulting And Other Expenses Business Development
ResearchConsultingAndOtherExpensesBusinessDevelopment
577000 USD
CY2017Q3 actg Revenueothersettlements
Revenueothersettlements
0 USD
actg Revenueothersettlements
Revenueothersettlements
0 USD
CY2018Q3 actg Revenueothersettlements
Revenueothersettlements
3470000 USD
actg Revenueothersettlements
Revenueothersettlements
3470000 USD
CY2017Q3 actg Revenues Paidup
RevenuesPaidup
35300000 USD
actg Revenues Paidup
RevenuesPaidup
57460000 USD
CY2018Q3 actg Revenues Paidup
RevenuesPaidup
7250000 USD
actg Revenues Paidup
RevenuesPaidup
70496000 USD
CY2017Q3 actg Revenues Salesbased
RevenuesSalesbased
1333000 USD
actg Revenues Salesbased
RevenuesSalesbased
4484000 USD
CY2018Q3 actg Revenues Salesbased
RevenuesSalesbased
3005000 USD
actg Revenues Salesbased
RevenuesSalesbased
8337000 USD
CY2017Q4 actg Royalties And Contingent Legal Fees Payable
RoyaltiesAndContingentLegalFeesPayable
1601000 USD
CY2018Q3 actg Royalties And Contingent Legal Fees Payable
RoyaltiesAndContingentLegalFeesPayable
7193000 USD
CY2018Q1 actg Royalties And Contingent Legal Fees Payable
RoyaltiesAndContingentLegalFeesPayable
3329000 USD
CY2016Q3 actg Secured Convertible Promissory Note
SecuredConvertiblePromissoryNote
20000000 USD
CY2016Q3 actg Secured Promissory Note Advance
SecuredPromissoryNoteAdvance
10000000 USD
CY2018Q3 actg Sharesof Investment Sold
SharesofInvestmentSold
1000000 shares
actg Unrealized Gain Losson Investment Warrants
UnrealizedGainLossonInvestmentWarrants
-9849000 USD
actg Unrealized Gain Losson Investments Common Stock
UnrealizedGainLossonInvestmentsCommonStock
-42278000 USD
CY2017Q1 actg Upfront Shares
UpfrontShares
60000 shares
CY2017Q1 actg Veritone Bridge Loan Advance1
VeritoneBridgeLoanAdvance1
1000000 USD
CY2017Q1 actg Veritone Bridge Loan Advance3and4
VeritoneBridgeLoanAdvance3and4
2000000 USD
CY2016Q3 actg Veritone Primary Warrant
VeritonePrimaryWarrant
50000000 USD
CY2017Q4 actg Writedownofdeferredtaxassets
Writedownofdeferredtaxassets
25261000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Period End Date
DocumentPeriodEndDate
2018-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000934549
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49639319 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
ACACIA RESEARCH CORP
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7956000 USD
CY2018Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9067000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
153000 USD
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10572000 USD
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4695000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
630000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-88000 USD
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-122000 USD
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P2Y
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
648996000 USD
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
650814000 USD
CY2017Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5625000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16711000 USD
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4952000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15560000 USD
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6029156 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4618618 shares
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3518070 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3549770 shares
us-gaap Asset Impairment Charges
AssetImpairmentCharges
28210000 USD
CY2017Q4 us-gaap Assets
Assets
308768000 USD
CY2018Q3 us-gaap Assets
Assets
220276000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
139695000 USD
CY2018Q3 us-gaap Assets Current
AssetsCurrent
157103000 USD
CY2018Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
30843000 USD
us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
0 USD
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
6000 USD
CY2018Q3 us-gaap Available For Sale Equity Securities Amortized Cost Basis
AvailableForSaleEquitySecuritiesAmortizedCostBasis
2930000 USD
CY2018Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
33848000 USD
CY2018Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
33773000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0 USD
CY2018Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
30837000 USD
CY2017Q4 us-gaap Available For Sale Securities Equity Securities Current
AvailableForSaleSecuritiesEquitySecuritiesCurrent
0 USD
CY2018Q3 us-gaap Available For Sale Securities Equity Securities Current
AvailableForSaleSecuritiesEquitySecuritiesCurrent
3011000 USD
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
81000 USD
us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
0 USD
us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
6000 USD
CY2017Q1 us-gaap Bridge Loan
BridgeLoan
4000000 USD
CY2017Q2 us-gaap Bridge Loan
BridgeLoan
4000000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
139052000 USD
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
101081000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
136604000 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109562000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-37971000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-27042000 USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50639926 shares
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49639319 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50639926 shares
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49639319 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
51000 USD
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
50000 USD
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
158489000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
132421000 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33115000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-93694000 USD
CY2017Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
158393000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
132022000 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-32784000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-93515000 USD
CY2017Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
13.6088
us-gaap Defined Benefit Plan Purchases Sales And Settlements
DefinedBenefitPlanPurchasesSalesAndSettlements
-10440000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16780000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.01
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15582000 USD
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.62
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.87
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.61
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.87
CY2017Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.02
CY2018Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.01
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
-32538000 USD
CY2018Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018Q3 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.15
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
2195000 USD
CY2018Q3 us-gaap Equity Method Investments
EquityMethodInvestments
8195000 USD
CY2018Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
735000 USD
CY2018Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3215000 USD
CY2018Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
817000 USD
CY2018Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
822000 USD
CY2018Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1682000 USD
CY2018Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
10876000 USD
CY2018Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18147000 USD
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12715000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26365000 USD
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6089000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16566000 USD
CY2017Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2248000 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2248000 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2248000 USD
CY2018Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
29210000 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
29210000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
158585000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
134919000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32558000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-92699000 USD
CY2017Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-116000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-130000 USD
CY2018Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
216000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2935000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
306000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
782000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6608000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1052000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-26450000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5877000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
874000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
183000 USD
CY2017Q3 us-gaap Interest Income Other
InterestIncomeOther
1100000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
13109000 USD
CY2018Q3 us-gaap Liabilities
Liabilities
18134000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
308768000 USD
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
220276000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9557000 USD
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16260000 USD
CY2017Q3 us-gaap Licenses Revenue
LicensesRevenue
36633000 USD
us-gaap Licenses Revenue
LicensesRevenue
61944000 USD
CY2018Q3 us-gaap Licenses Revenue
LicensesRevenue
13725000 USD
us-gaap Licenses Revenue
LicensesRevenue
82303000 USD
CY2017Q2 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
20700000 USD
CY2017Q3 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
0 USD
us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
0 USD
CY2018Q3 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
5539000 USD
us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
5539000 USD
CY2017Q4 us-gaap Minority Interest
MinorityInterest
1358000 USD
CY2018Q3 us-gaap Minority Interest
MinorityInterest
1844000 USD
CY2018Q1 us-gaap Minority Interest
MinorityInterest
1666000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
645000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4606000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-73539000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29935000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
34923000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7499000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
158465000 USD
us-gaap Net Income Loss
NetIncomeLoss
132383000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-33195000 USD
us-gaap Net Income Loss
NetIncomeLoss
-93660000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-10440000 USD
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
4000000 USD
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
179000 USD
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
4000000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3552000 USD
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1874000 USD
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
164000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1423000 USD
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
321000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
796000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-473000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-506000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
35000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
229000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
424945000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
65883000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
158326000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
132142000 USD
CY2017Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-96000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-399000 USD
CY2018Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
331000 USD
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33195000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-93660000 USD
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
158326000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
132143000 USD
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-33195000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-93660000 USD
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
159027000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
154861000 USD
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-27595000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-56870000 USD
CY2017Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
37075000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
81886000 USD
CY2018Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
18688000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
118132000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-442000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-19942000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4963000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-35829000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
207000 USD
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
183000 USD
CY2017Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
9000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
18000 USD
CY2018Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-5000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-109000 USD
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
15000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
20000 USD
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
85000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
75000 USD
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
CY2017Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
0 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
0 USD
CY2018Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2202000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2202000 USD
CY2017Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
0 USD
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
0 USD
CY2018Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
0 USD
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
4000000 USD
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
202142000 USD
CY2016Q3 us-gaap Timesharing Transactions Stated Interest Rate For Notes Receivable
TimesharingTransactionsStatedInterestRateForNotesReceivable
0.06
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
3.89
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
31514000 USD
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
7000000 USD
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2938000 USD
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3121000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-4634000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
386920000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
32508000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
680000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
257000 USD
CY2017Q3 us-gaap Profit Loss
ProfitLoss
158369000 USD
us-gaap Profit Loss
ProfitLoss
131984000 USD
CY2018Q3 us-gaap Profit Loss
ProfitLoss
-32864000 USD
us-gaap Profit Loss
ProfitLoss
-93481000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-320018000 USD
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-411172000 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-317512000 USD
CY2017Q3 us-gaap Revenues
Revenues
36633000 USD
us-gaap Revenues
Revenues
61944000 USD
CY2018Q3 us-gaap Revenues
Revenues
13725000 USD
us-gaap Revenues
Revenues
82303000 USD
CY2017Q3 us-gaap Royalty Expense
RoyaltyExpense
0 USD
us-gaap Royalty Expense
RoyaltyExpense
4939000 USD
CY2018Q3 us-gaap Royalty Expense
RoyaltyExpense
1181000 USD
us-gaap Royalty Expense
RoyaltyExpense
24166000 USD
CY2018Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.44
us-gaap Share Based Compensation
ShareBasedCompensation
13068000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
172000 USD
CY2018Q3 us-gaap Short Term Investments
ShortTermInvestments
66386000 USD
us-gaap Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2019-02-28
CY2018Q3 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
20000000 shares
CY2018Q3 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
15366000 shares
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
294301000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
200298000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
295659000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1190420 shares
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1729408 shares
CY2018Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2919828 shares
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
34640000 USD
CY2018Q3 us-gaap Treasury Stock Value
TreasuryStockValue
39272000 USD
CY2017Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
158979000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
146281000 USD
CY2018Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-22377000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-52127000 USD
CY2017Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
45740 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
221735 shares
CY2018Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50599974 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50684725 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49557748 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50080234 shares
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50554234 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50462990 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49557748 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50080234 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of equity instruments, stock-based compensation expense including the valuation of profits interests, impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.</font></div></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentrations. </font><font style="font-family:inherit;font-size:10pt;">Three</font><font style="font-family:inherit;font-size:10pt;"> licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;">44%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">17%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and one licensee accounted for </font><font style="font-family:inherit;font-size:10pt;">73%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the </font><font style="font-family:inherit;font-size:10pt;">nine months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">. One licensee accounted for </font><font style="font-family:inherit;font-size:10pt;">96%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and three licensees accounted for </font><font style="font-family:inherit;font-size:10pt;">57%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">23%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the </font><font style="font-family:inherit;font-size:10pt;">nine months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">. For the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">61%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. For the three and nine months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">3%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">39%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions. The Company does not have any material foreign operations. Three licensees individually represented approximately </font><font style="font-family:inherit;font-size:10pt;">57%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">22%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">12%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">. One licensee individually represented approximately </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at December 31, 2017. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

Files In Submission

Name View Source Status
0000934549-18-000092-index-headers.html Edgar Link pending
0000934549-18-000092-index.html Edgar Link pending
0000934549-18-000092.txt Edgar Link pending
0000934549-18-000092-xbrl.zip Edgar Link pending
actg-20180930.xml Edgar Link completed
actg-20180930.xsd Edgar Link pending
actg-20180930_cal.xml Edgar Link unprocessable
actg-20180930_def.xml Edgar Link unprocessable
actg-20180930_lab.xml Edgar Link unprocessable
actg-20180930_pre.xml Edgar Link unprocessable
actg10q09302018.htm Edgar Link pending
ex31109302018.htm Edgar Link pending
ex31209302018.htm Edgar Link pending
ex32109302018.htm Edgar Link pending
ex32209302018.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
graphicactga02a13.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending